Sodium Reduction: How Big Might the Risks and Benefits Be?

Area of Science:

• Public Health
• Cardiology
• Nutrition Science

Background:

• Cardiovascular diseases (CVD) are the leading global cause of death, with elevated blood pressure as the primary risk factor.
• Excess dietary sodium intake is a major contributor to hypertension, although its direct link to cardiovascular outcomes has been debated.
• Previous estimates suggest millions of deaths annually are attributable to excess sodium, based on assumptions of a direct, linear relationship with CVD risk and a minimum risk threshold of 2.0 g/day.

Purpose of the Study:

• To re-evaluate the association between sodium intake and cardiovascular disease (CVD) risk, considering recent evidence challenging U-shaped curves.
• To explore the potential of salt substitution as a safe, effective, and scalable intervention for reducing CVD burden.
• To highlight the need for robust clinical data to support the widespread adoption of salt substitutes.

Main Methods:

• Review of recent data suggesting that U-shaped sodium-risk associations are likely due to confounding factors.
• Assessment of the potential for blood pressure reduction and CVD risk mitigation through salt substitution.
• Reference to an ongoing large-scale randomized trial evaluating the impact of salt substitution on major cardiovascular events and mortality.

Main Results:

• Recent data support a direct association between sodium intake and CVD risk, refuting confounding-driven U-shaped curves.
• Cardiovascular risk may continue to decrease below 2.0 g/day sodium intake, and the avoidable disease burden may be underestimated due to age-related blood pressure increases.
• Salt substitution demonstrates blood pressure-lowering effects comparable to monotherapy, with potential for community-wide application due to low cost and ease of use.

Conclusions:

• Salt substitution presents a significant opportunity for public health interventions to combat cardiovascular diseases.
• Further research, including the ongoing large-scale trial, is crucial to provide definitive data on clinical benefits and safety, paving the way for widespread implementation.
• Defining safe, effective, and scalable interventions is essential for achieving health benefits from sodium reduction strategies.